These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15170966)

  • 1. [Current imaging methods in Graves' ophthalmopathy].
    Szúcs-Farkas Z; Galuska L; Nagy VE
    Orv Hetil; 2004 Apr; 145(17):891-9. PubMed ID: 15170966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging in Graves' orbitopathy.
    Kirsch E; von Arx G; Hammer B
    Orbit; 2009; 28(4):219-25. PubMed ID: 19839878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' orbitopathy: current imaging procedures.
    Kirsch E; Hammer B; von Arx G
    Swiss Med Wkly; 2009 Oct; 139(43-44):618-23. PubMed ID: 19950023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difficulties in diagnosing Graves' ophthalmopathy--case report].
    Sikorska ZW; Stafiej JM
    Przegl Lek; 2004; 61(8):835-7. PubMed ID: 15789910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between computed tomography and magnetic resonance imaging in Graves' orbitopathy.
    Nianiaris N; Hurwitz JJ; Chen JC; Wortzman G
    Can J Ophthalmol; 1994 Feb; 29(1):9-12. PubMed ID: 8180879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in Graves' ophthalmopathy imaging.
    Kahaly GJ
    J Endocrinol Invest; 2004 Mar; 27(3):254-8. PubMed ID: 15165001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
    Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
    Hosten N; Schörner W; Lietz A; Wenzel KW
    Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonic B-scan measurement of the extra-ocular muscles in Graves' orbitopathy.
    Willinsky RA; Arenson AM; Hurwitz JJ; Szalai J
    J Can Assoc Radiol; 1984 Jun; 35(2):171-3. PubMed ID: 6384227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
    Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM
    Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital lymphoma mimicking ophthalmopathy in a patient with Graves'.
    Moura Neto A; Denardi FC; Delamain MT; Tambascia MA; Vassallo J; Caldato R; Zantut-Wittmann DE
    Am J Med Sci; 2012 Nov; 344(5):418-21. PubMed ID: 22885624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
    Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H
    Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid eye disease: review and case reports.
    McGarvey EJ
    J Am Optom Assoc; 1990 Sep; 61(9):689-700. PubMed ID: 2212462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Witte A; Landgraf R; Markl A; Boergen KP; Hasenfratz G; Pickardt CR
    Klin Wochenschr; 1985 Oct; 63(19):1000-4. PubMed ID: 3840854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2005 Apr; 15(4):358-63. PubMed ID: 15876160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative CT of the orbit in Graves' disease.
    Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
    Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.